CSTL — CASTLE BIOSCIENCES INC
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1447362 ·
Last close
$19.69
Market Cap
$597.20M
52W High
$30.50
52W Low
$17.72
ADV30
437,520
Next earnings
2026-08-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 83,679,000 | 63,146,000 | -18,407,000 | -14,522,000 | 547,805,000 | 63,764,000 | 86,389,000 |
| Dec 2025 | 87,010,000 | 68,695,000 | -3,827,000 | -2,332,000 | 578,556,000 | 116,729,000 | 107,683,000 |
| Sep 2025 | 83,043,000 | 64,339,000 | -6,804,000 | -501,000 | 562,786,000 | 85,556,000 | 95,740,000 |
| Jun 2025 | 86,188,000 | 68,562,000 | -4,251,000 | 4,523,000 | 544,729,000 | 82,233,000 | 89,353,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$64,347,000
Investing CF
$-60,367,000
Financing CF
$-6,960,000
CapEx
$-36,021,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.85
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-224,284,000
Inventory
$10,254,000
Receivables
$43,382,000
ST Investments
$182,776,000
EBIT TTM
$-29,428,000
Pretax Income TTM
$-29,514,000
Interest Exp TTM
$86,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$339,920,000
EBITDA
$-18,353,000
Free Cash Flow
$12,890,500
Enterprise Value
$372,235,744
Total Cash
$261,684,992
Total Debt
$36,724,000
Shares Out
30,329,952
Trailing EPS
$-0.42
Book Value
$15.23
ROE
-2.8%
ROA
-4.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 344,229,000 | -42,810,000 | -24,158,000 | 578,556,000 | 107,683,000 | — | 64,347,000 |
| Dec 2024 | 332,069,000 | 8,670,000 | 18,245,000 | 531,235,000 | 75,400,000 | — | 64,866,000 |
| Dec 2023 | 219,788,000 | -67,977,000 | -57,466,000 | 453,340,000 | 62,071,000 | — | -5,626,000 |
| Dec 2022 | 137,039,000 | -91,142,000 | -67,138,000 | 447,329,000 | 48,179,000 | — | -41,655,000 |
TTM Snapshot
Revenues TTM
$208,981,000
NetIncome TTM
$-30,025,000
OpCashFlow TTM
$0
Assets (Latest)
$531,235,000
Forward EPS
$-0.90
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SRTA | Strata Critical Medical, Inc. | $531.27M | $6.14 | — |
| EHAB | Enhabit, Inc. | $706.91M | $13.80 | — |
| FLGT | Fulgent Genetics, Inc. | $501.84M | $17.67 | — |
| TOI | Oncology Institute, Inc. | $458.92M | $4.59 | — |
| LMRI | Lumexa Imaging Holdings, Inc. | $784.98M | $8.17 | — |
News headlines (Yahoo Finance, 1h cache)
How The Castle Biosciences (CSTL) Story Is Shifting After Solid Q1 And Lower Targets
2026-05-24 16:13 · Yahoo
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
2026-05-13 11:00 · Yahoo
Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation
2026-05-12 11:00 · Yahoo
Castle Biosciences, Inc. Q1 2026 Earnings Call Summary
2026-05-07 00:22 · Yahoo
Castle Biosciences Q1 Earnings Call Highlights
2026-05-07 00:07 · Yahoo
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates
2026-05-06 22:30 · Yahoo
Castle Biosciences Reports First Quarter 2026 Results
2026-05-06 20:05 · Yahoo
Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises
2026-05-06 16:06 · Yahoo
OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook
2026-05-06 16:01 · Yahoo
EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus
2026-05-06 15:57 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.